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Strategies for grouping per- and polyfluoroalkyl
substances (PFAS) to protect human and
environmental health
Ian T. Cousins, *a Jamie C. DeWitt, b Juliane Glüge, c Gretta Goldenman,d
Dorte Herzke, ef Rainer Lohmann, g Mark Miller,h Carla A. Ng, i
Martin Scheringer, c Lena Vierkej and Zhanyun Wang k
Grouping strategies are needed for per- and polyfluoroalkyl substances (PFAS), in part, because it would be
time and resource intensive to test and evaluate the more than 4700 PFAS on the global market on
a chemical-by-chemical basis. In this paper we review various grouping strategies that could be used to
inform actions on these chemicals and outline the motivations, advantages and disadvantages for each.
Grouping strategies are subdivided into (1) those based on the intrinsic properties of the PFAS (e.g.
persistence, bioaccumulation potential, toxicity, mobility, molecular size) and (2) those that inform risk
assessment through estimation of cumulative exposure and/or effects. The most precautionary grouping
approach of those reviewed within this article suggests phasing out PFAS based on their high persistence
alone (the so-called “P-sufficient” approach). The least precautionary grouping approach reviewed
advocates only grouping PFAS for risk assessment that have the same toxicological effects, modes and
mechanisms of action, and elimination kinetics, which would need to be well documented across
different PFAS. It is recognised that, given jurisdictional differences in chemical assessment philosophies
and methodologies, no one strategy will be generally acceptable. The guiding question we apply to the
reviewed grouping strategies is: grouping for what purpose? The motivation behind the grouping (e.g.
determining use in products vs. setting guideline levels for contaminated environments) may lead to
different grouping decisions. This assessment provides the necessary context for grouping strategies
such that they can be adopted as they are, or built on further, to protect human and environmental
health from potential PFAS-related effects.
Environmental signicance
PFAS comprise more than 4700 individual substances that are used in many, highly diverse applications in society. All PFAS are very persistent (if PFAS with
persistent transformation products are considered as persistent substances, as is the case under REACH) and several PFAS are also known to be bioaccumulative
and toxic. However, for most PFAS there are insufficient data to facilitate chemical assessments. Generating these missing data on a chemical-by-chemical basis
is too resource intensive and it is therefore essential to identify groups of similar PFAS that can be assessed together. Here we discuss various grouping
approaches and their advantages and limitations. The structural diversity of PFAS poses a challenge to grouping. However, some kind of grouping approach, or
a combination of several different approaches, will be needed for the future assessment and management of PFAS.
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Introduction
Buck et al.1 provided the rst class denition of per- and poly-
uoroalkyl substances (PFAS) as “the highly uorinated
aliphatic substances that contain 1 or more C atoms on which
all the H substituents. have been replaced by F atoms, in such
a manner that they contain the peruoroalkyl moiety CnF2n+1–”
(where n is equal to or greater than 1, i.e. the structure must
contain at least one CF3– group). A more recent and broader
denition by the Organisation for Economic Co-operation and
Development (OECD)/United Nations Environment Programme
(UNEP) Global PFC Group2 dened PFAS as chemicals with at
least one peruorocarbon moiety (–CnF2n–). PFAS therefore
comprise a diverse group of chemistries with the common
feature of the fully or “per”-uorinated carbon chain.
Structurally diverse PFAS are used in a wide variety of
commercial products and industrial applications. In the 2018
OECD PFAS list2 over 4700 CAS numbers were identied for
PFAS on the global market. For the majority of PFAS, little or no
data on uses, properties and effects are available to determine
how these chemicals may impact the health of living organ-
isms.3–6 Our current understanding of biological impact is
based primarily on studies of four PFAS, peruorooctane
sulfonic acid (PFOS), peruorooctanoic acid (PFOA), per-
uorohexane sulfonic acid (PFHxS), and peruorononanoic
acid (PFNA).7 Epidemiological studies of human populations
suggest that PFAS may act as endocrine and metabolic dis-
ruptors, increase cholesterol levels, adversely impact the
immune system, and cause cancer.7 These data are supported
by studies in laboratory animals showing changes in liver,
thyroid, immune and pancreatic function.7
But researching individual chemicals is both expensive and
time consuming. It can take many years to gather the evidence
needed under regulatory regimes to restrict harmful chemicals.
It is becoming increasingly apparent that to effectively protect
the public and environment from the wide range of possible
PFAS-related environmental and human health effects, strate-
gies should be sought to group PFAS for action, e.g. for guiding
regulatory and voluntary phase-out actions, etc., rather than to
address them chemical-by-chemical. For example, in the recent
Zurich Statement,8 the authors recommended “that actions
need to address groups of PFAS rather than individual chem-
icals and that such a grouping approach needs to be scienti-
cally sound.” It was further recognized “that a grouping
approach requires a better mechanistic understanding of the
physicochemical and toxicological properties of PFAS as well as
additional data that can be used to support grouping
approaches for PFAS.”
Between 2000 and 2002,9 aer about 50 years of continuous
manufacture, 3M phased out all PFAS products derived from
peruorooctane sulfonyl uoride (POSF; C-8) and its C-6 and C-
10 homologues, which represented the rst large-scale
grouping of hundreds of PFAS for voluntary phase-out. Shortly
thereaer, in 2006, eight major PFAS manufacturers committed
to eliminating the global use and emissions of PFOA, its longer-
chain homologues, and their precursors by 2015 through the
PFOA Stewardship program10 agreement with the US Environ-
mental Protection Agency (US EPA).
In conjunction with these phase-outs, the uorochemical
industry introduced another grouping approach, namely the
concept of “long-chain” and “short-chain” peruoroalkyl acids
(PFAAs),11 dening long-chain PFAAs as only peruoroalkyl
carboxylic acids (PFCAs) with $7 peruorinated carbons and
peruoroalkane sulfonic acids (PFSAs) with $6 peruorinated
carbons. While emerging evidence showed long-chain PFAAs
are bioaccumulative and toxic, the PFAS manufacturing
industry held that short-chain PFAAs were not, and thus one of
the strategies of the PFAS manufacturing industry was to
replace long-chain PFAAs with their short-chain homologues.12
Another substitution strategy is to replace long-chain PFAAs
with substances containing peruoroalkyl ether moieties (e.g.
per- and polyuoroalkyl ether carboxylic and sulfonic acids
(PFECAs and PFESAs)).12
It is now apparent that this industry substitution strategy for
long-chain PFAAs requires reconsideration given (1) the wide-
spread environmental contamination (including drinking water
sources) by short-chain PFAAs13 and peruoroalkyl ether acids14
due to their high environmental mobility and (2) the listing of
both hexauoropropylene oxide dimer acid (HFPO-DA, some-
times referred to as GenX), a PFOA-replacement introduced by
DuPont in 2009 that contains peruoroalkyl ether moieties, and
peruorobutane sulfonic acid (PFBS), a short-chain PFAA that is
the ultimate degradation product of 3M's replacement chem-
istry (introduced in 2003), as Substances of Very High Concern
(SVHCs) under the EU REACH Regulation.15
Given the number of substitutions of long-chain PFAAs with
other PFAS that are now also considered to be problematic,
there is a need for more effective grouping strategies for the
regulation of PFAS than the current approach of regulating only
long-chain PFAAs and related substances. In the Madrid State-
ment,16 more than 200 scientists and regulators suggested that
PFAS should be managed as a class, and that production and
use should be limited. This grouping of all PFAS for phase-out is
based on concerns regarding the high persistence of PFAS, the
lack of knowledge on chemical structures, properties, uses, and
toxicological proles of most PFAS currently in use, and the
need for informed substitutions of problematic PFAS chemis-
tries.16 A counterpoint to regulating PFAS as a class, authored by
the FluoroCouncil17 in response to theMadrid Statement, stated
(among other things) that PFAS are a structurally diverse group
exhibiting “important differences between the health and
environmental impacts”, and that “uorotechnology is essen-
tial technology for many aspects of modern life”.
The Montreal Protocol's concept of essential use has been
put forward as an approach for reducing exposure to PFAS, by
phasing out all non-essential uses of PFAS.18 While such
a phase-out of PFAS is likely not feasible in the short term, it is
not an insurmountable challenge in the longer term. Indeed,
within the European Union (EU), there are already discussions
underway for a restriction proposal for all non-essential uses of
PFAS,19,20 although it is not yet known how “essential use” will
be dened. Innovation, in conjunction with regulation and
economic incentives for the development of new technologies,
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should in time provide functional alternatives to even current
essential uses of PFAS.18 In cases where the uses of PFAS are
seen as “necessary for health, safety or is critical for the func-
tioning of society”16 but no functional alternatives with
favourable hazard properties are currently available, certain
uses of PFAS will probably continue, at least in the short term.18
However, the use of the grouping strategies presented here
could provide opportunities for market adjustment, and spark
more voluntary efforts to reduce non-essential uses.18
The aims of this paper are to discuss (1) current and
potential grouping strategies that inform PFAS assessment for
various control actions, with advantages and disadvantages for
each, (2) highlight motivations for action that could guide use of
specic grouping approaches and (3) outline the way forward
and remaining challenges in advancing these grouping
approaches.
Motivations for grouping
The method used to group PFAS depends on the type of action
intended. Grouping PFAS may have benets, for example: (1) to
more efficiently protect human and environmental health, (2) to
avoid animal testing through read across,21 (3) for product
labelling and consumer education (e.g. for interpretation of
a label such as “PFAS free”), or (4) to manage clean-up of
contaminated sites.
Most existing grouping approaches have been developed to
protect human and environmental health from potential
adverse effects resulting from exposure to the multiple PFAS in
commerce. Moreover, further motivations for grouping of PFAS
are based on their environmental and biological persistence,
the high number of individual PFAS, and the lessons learned
from recent industrial substitution strategies.
Proactive strategies concerning new or continued use of
PFAS may benet from more precautionary grouping
approaches because these decisions will directly impact future
exposures and because their implementation – at least avoid-
ance of non-essential uses – will always be less costly than
retrospective risk assessment and remediation. On the other
hand, decisions for how to group already emitted PFAS for the
establishment of drinking water guidelines or environmental
cleanup levels will have profound impacts on enforcement
including costs and resource needs. It may therefore be neces-
sary, in resource-constrained settings, to more strictly prioritize
cleanup levels on the basis of established toxicological risk.
Grouping approaches
Here existing grouping approaches to protecting human and
environmental health are subdivided into (1) those based on the
intrinsic properties of the PFAS and (2) those that inform risk
assessment through estimation of cumulative exposure and/or
effects (see Fig. 1). National or international chemical assess-
ments rely on intrinsic properties of the chemical, including its
persistence (P), bioaccumulation (B) and toxicity (T). This “PBT
approach” can be found for example in the EU REACH Regu-
lation.22 Under REACH, substances can also be identied as
“Substances of Very High Concern” (SVHC) if they are very
persistent (vP) and very bioaccumulative (vB) meaning that if
these criteria can be met, toxicity does not require
consideration.
The approaches that inform risk assessment, on the other
hand, consider anticipated exposure when determining
whether or not an adverse effect to human health or the envi-
ronment may occur. For example, the point of departure for
establishing acceptable risk could be the no observed adverse
effect level (NOAEL) for a critical toxicological endpoint. The
NOAEL can then be compared to either the external dose or
exposure (e.g. concentration in exposure medium) or internal
dose or exposure (e.g. serum or tissue concentration) to deter-
mine the risks.
Risk assessment has typically been performed on a chemical-
by-chemical basis, but there is some current focus on devel-
oping methods for combined risk assessment through estima-
tion of cumulative exposure (e.g. total organouorine (TOF) or
extractable or adsorbable organouorine (EOF/AOF)) and/or
effects (e.g. additive).23 Such combined risk assessment is
challenging for multiple PFAS, given that sufficient toxicity data
are only available for relatively few (<20) substances.7
Measurement of exposure can be achieved for more substances,
but may be constrained by the lack of knowledge of what/how to
measure and also lack of analytical standards.
Each individual approach is discussed in more detail in the
following sections. It is important to note that the individual
grouping approaches were developed for different purposes,
have different data needs, and therefore cannot always be
directly compared to each other. The selection of the grouping
approach needs to account for the specic protection goal, data
requirements and enforcement techniques.
Grouping approaches based on
intrinsic properties
Grouping according to the “P-sufficient” approach
The continuous release of persistent chemicals will lead to
widespread, long-lasting, and increasing contamination, which
will inevitably result in increasing probabilities of known and
unknown adverse effects on human health and the environ-
ment.24 The peruoroalkyl (CnF2n+1–) and peruoroether
(CnF2n+1–O–CmF2m–) moieties are highly persistent under envi-
ronmental conditions.4 Although some polyuoroalkyl
substances (so called “precursors”) may degrade in the envi-
ronment and biota, they all ultimately (partially) transform into
highly stable end products, which are usually the persistent
PFAAs.3 This view is consistent with the REACH Regulation that
all chemicals with persistent transformation products should
be classied as persistent.22 Based on this denition, all PFAS
are therefore considered to be very persistent in environmental
media, and under the proposed “P-sufficient” approach all PFAS
would be managed as a single group.
An advantage of this approach is that it is easily imple-
mentable to all PFAS for non-experts, i.e. non-experts will not
need to ask if a (new) PFAS belongs to the group or not. A
1446 | Environ. Sci.: Processes Impacts, 2020, 22, 1444–1460 This journal is © The Royal Society of Chemistry 2020
































































































disadvantage of the “P-sufficient approach” is that no legal
precedent has been made in any jurisdiction, although the idea
of regulating highly persistent chemicals and microplastics is
being explored within the EU.25,26
Grouping according to the PBT/vPvB approach
As mentioned in the introduction, PFAAs have been grouped
into long-chain and short-chain PFAAs, where long-chain PFAAs
are considered bioaccumulative in animals and short-chain
PFAAs are not.11 A major disadvantage in the current grouping
of long- versus short-chain PFAAs to determine if PFAS are
bioaccumulative is that the denitions of long- and short-chain
PFAAs only apply to PFCAs and PFSAs;11 however, it has been
suggested that there are other PFAS that are bioaccumulative.
To more accurately dene those PFAS that are bioaccumulative,
new grouping approaches would be required; a few suggestions
are provided below.
Fig. 1 Grouping approaches for PFAS.
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There are already a number of PFAS that are suggested to be
bioaccumulative according to observations from bio-
accumulation experiments. For example, certain peruoroalkyl
phosphonic and phosphinic acids (PFPAs and PFPIAs) can only
be slowly eliminated from rainbow trout27 and rats,28 similarly
to long-chain PFCAs and PFSAs.29 There is also evidence that
peruorotripropyl amine is bioaccumulative based on the long
elimination half-lives observed in the liver and spleen of rats.30
Peruorooctane is also potentially bioaccumulative based on
bioconcentration factor (BCF) measurements in European carp
(BCF up to 3200 L kg1) and rice sh (BCF up to 13 600 L kg1).31
Finally, chlorinated PFESAs, predominately the so-called 6:2 Cl-
PFASA (oen called F-53B, CAS no. 73606-19-6), and a novel
PFECA, peruoro-2-[(propoxy)propoxy]-1-propanoate have been
shown to bioaccumulate in biota and human serum.32–35
Indications of bioaccumulation that need further evaluation
are the observations of a number of emerging and novel PFAS in
top predators including humans. For example, peruoro-4-
ethylcyclohexane sulfonate has been detected in top predator
sh in the Great Lakes36 and in crucian carp in China.37 PFPIAs,
predominately 6:8 PFPIA (cormorants and pike) and 6:6 PFPIA
(dolphins), have been observed in biota in North American
inland and coastal waters.38 PFPAs, predominately
peruorohexyl phosphonate (PFHxPA), have been detected in
a Norwegian human cohort.39
Fig. 2 illustrates the structures of some PFAS suggested to be
bioaccumulative. A common feature of the PFAS in Fig. 2 is that
they contain at least six peruorinated carbons. The head group
of PFAAs is also known to inuence their bioaccumulation
potential; for example, it is well known that PFSAs are more
bioaccumulative than PFCAs with the same peruorinated
carbon chain length.11
Both computational and empirical methods have been
explored to estimate protein binding affinity. In vitro methods
include, among others, equilibrium dialysis40 and uorescence
displacement.41,42 In a recent paper, Yang et al.43 used a non-
target screening approach to identify novel PFAS present in
aqueous lm forming foams (AFFF) that bind to human liver
fatty acid binding protein. Computational methods are based
on structure–property relationships and could potentially be
used to estimate the bioaccumulation potential of novel and
emerging PFAS. For example, the protein affinity of certain
legacy and novel PFAS was recently estimated using molecular
dynamic approaches,44 and protein affinity is a key determinant
of bioaccumulation potential. Such structure–property rela-
tionships may also aid in estimating the elimination half-lives
Fig. 2 Chemical structures of various potentially bioaccumulative PFAS (other than the already well-known long-chain PFAAs). Note that this
figure only provides a few examples of potentially bioaccumulative PFAS from the wider universe of PFAS.
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of PFAS, which is another important factor in determining
bioaccumulation potential. Predictive approaches for bio-
accumulation potential will be especially important for
informing grouping, as they are proactive and resource-efficient
in comparison to biomonitoring and laboratory testing (in vitro
or in vivo testing).
Short-chain PFAAs have not been reported to bioaccumulate
in animals,11 but are known to bioaccumulate in above-ground
plant tissues (shoots, leaves and fruit).45–48 An inverse relation-
ship has been observed between peruoroalkyl chain length
and BCFs of PFAAs in above-ground plant tissues for edible
crops grown in sludge-amended soils.47 In regions where the
soil is highly contaminated with short-chain PFAAs, human
exposure from consumption of crops can become an important
pathway.49
A fundamental limitation of grouping according to bio-
accumulation potential (B) is that for highly persistent chem-
icals, B may become less relevant if a high exposure is achieved
via other pathways than uptake and accumulation within the
body. It has been argued50 that B is not a sufficient criterion for
protecting against poorly reversible effects because the resi-
dence time of highly persistent chemicals in the environment is
oen much greater than their residence time in humans and
biota, which means that levels in organisms will be poorly
reversible regardless of the magnitude of B. The limitations of
the PBT and vPvB assessment criteria were the motivation for
the development of other complementary chemical manage-
ment approaches such as the “P-sufficient” and the “PMT/
vPvM” approaches. On the other hand, the PBT/vPvB approach
is a well-established regulatory framework.
Grouping according to the PMT/vPvM approach
The German Environment Agency (UBA) has recently proposed
a PMT/vPvM approach for identifying substances that may pose
a threat to sources of drinking water.51 The approach presents
and discusses updated guidelines for using the REACH regis-
tration process to identify persistent, mobile, and toxic (PMT)
substances as well as very persistent and very mobile (vPvM)
substances. The motivation for this approach is to pinpoint
substances that might require control to protect waters used as
sources for drinking water or food production. The PMT
approach classies substances considered persistent in the
environment (P), mobile in the aquatic environment (M) and
toxic (T). For substances identied as very persistent (vP) and
very mobile (vM), it is not necessary to consider toxicity data.51
Under this concept, the short-chain PFAAs and many other
replacements of long-chain PFAAs such as HFPO-DA, which are
both vP and vM, would be identied.
A consequence of introducing the PMT/vPvM approach is
that, in combination with the existing PBT/vPvB approach
under REACH, a wide range of substances that are vP would be
covered. Hydrophobic substances with a high octanol–water
partition coefficient (KOW) (e.g. KOW cutoff of log KOW > 5 under
the Stockholm Convention on Persistent Organic Pollutants)
would be covered by the vPvB approach, and hydrophilic
substances with low KOW (a cutoff of log KOW < 4 under the
proposed PMT/vPvM approach) would be covered by the vPvM
approach. Therefore, the authors of the “P-sufficient” approach
argue that partitioning properties such as KOW, KOC (organic-
carbon-water partition coefficient) and the BCF are irrelevant
and that PFAS should be managed according to their high
persistence alone.24 Similar to the “P-sufficient approach” the
PMT/vPvM approach is still a proposal and not currently
broadly implemented under REACH.
Grouping some uoropolymers as “polymers of low concern”
PFAS are broadly subdivided into low molecular weight
substances and uorinated polymers.1 There are three
subclasses of uorinated polymers that meet the PFAS struc-
tural denition and these are termed: uoropolymers, per-
uoropolyethers and side-chain uorinated polymers.1
According to Buck et al.,1 uoropolymers are a distinct subset of
uorinated polymers made by (co)polymerization of olenic
monomers, at least one of which contains uorine bound to one
or both of the olenic carbon atoms, to form a carbon-only
polymer backbone with uorine atoms directly attached to it,
e.g., polytetrauoroethylene (PTFE).
It was recently suggested that a subset of uoropolymers
should be considered distinct from other uorinated polymers
based on international criteria for “polymers of low concern”
(PLC) due to (among other things) their high molecular weight,
narrow molecular weight distribution, negligible oligomer
content and organic and inorganic leachables.52 Classication
as PLC may exempt the manufacturers of certain uoropol-
ymers from certain regulatory notication requirements. Inte-
gration of the PLC criteria into a risk management framework
may differ from country to country according to individual
regulatory mandate.52 Although a recent framework for polymer
risk assessment recommended consideration of impacts
throughout the lifecycle of a polymeric product,53 Henry et al.52
limited their assessment of uoropolymers to the use phase.
However, there are serious concerns regarding the environ-
mental impacts of uoropolymers during manufacture
(“beginning of life”) and waste management (“end of life”) that
need to be addressed. Specically: (i) some uoropolymers (e.g.
PTFE ne powder) are still manufactured in Asia using pro-
cessing aids containing hazardous long-chain PFAAs (e.g.
PFOA), which are widely distributed in the Asian environment54
and can undergo long-range global transport,55,56 (ii) there are
concerns among scientists and regulators regarding the
substitute processing aids used (e.g. HFPO-DA is now an SVHC
under the EU REACH regulation),15 (iii) a wide range of poten-
tially hazardous byproducts have been observed in the envi-
ronment near uoropolymer manufacturing sites,14,57,58 (iv)
environmental emissions of these persistent polymers during
use and at end of life are problematic given the current concern
regarding persistent microplastics in the environment (even if
uoropolymer plastic waste is of relatively low volume),59 and (v)
the best available technology for treatment of solid wastes is
currently incineration, from which emissions of harmful
chemicals including certain PFAS could occur if incineration is
not operated according to international guidelines.60 The PLC
This journal is © The Royal Society of Chemistry 2020 Environ. Sci.: Processes Impacts, 2020, 22, 1444–1460 | 1449
































































































criteria should be applied on a product-by-product basis
because individual uoropolymer products (e.g. due to different
impurity levels) may not meet the PLC criteria.
Grouping approaches that inform risk
assessment
Arrowhead approach: grouping PFAAs together with their
precursors
The so-called “arrowhead approach” is dened as when
a representative PFAS (usually a PFAA) is managed together with
its salts and precursors. The approach represents the dominant
current approach to grouping PFAS for risk assessment and risk
management globally. Industry have used the approach in
voluntary phase-out actions (e.g. 3M 9) of PFAS chemistries and
it is applied globally in PFAS regulations. For example, precur-
sors to long-chain PFAAs have been grouped together with
specic PFAAs in risk management (e.g. under REACH,61,62 in
the Stockholm Convention,63,64 see Table 1, or are currently
under discussion, see Table 2) given that these precursor
substances will transform to an “arrowhead substance of
concern” (i.e. the long-chain PFAAs that have PBT properties) in
the environment, in biota, or in humans. There is no indication
of how many substances, past or present, are covered by de-
nitions such as, “PFOA, its salts and PFOA-related compounds”.
There are thousands of substances that can theoretically be
broken down into PFOA, but it is not clear which of them are or
have been used.
Although the arrowhead approach is an efficient way of
assessing and regulating large groups of chemicals simulta-
neously there are some limitations. One limitation is that the
approach may overlook the risks from the parent PFAS them-
selves, or intermediate degradation products that are formed
along the pathway to the presumed arrowhead degradation
products. For example, a recent study demonstrated that 6:2
uorotelomer alcohol (6:2 FTOH) is signicantly more toxic to
rodents than peruorohexanoic acid (PFHxA).65 The authors
Table 1 PFAAs and their precursors that have been grouped together
Substances What is included Context
PFOA, its salts and
PFOA-related compounds63
Peruorooctanoic acid (PFOA), its salts and PFOA-related
compounds means the following: (i) peruorooctanoic acid
(PFOA; CAS no. 335-67-1), including any of its branched
isomers; (ii) its salts; (iii) PFOA-related compounds which, for
the purposes of the convention, are any substances that
degrade to PFOA, including any substances (including salts
and polymers) having a linear or branched peruoroheptyl





The following compounds are not included as PFOA-related
compounds: (i) C8F17–X, where X ¼ F, Cl, Br; (ii)
uoropolymers that are covered by CF3[CF2]n–R0, where R0 ¼
any group, n > 16; (iii) peruoroalkyl carboxylic and
phosphonic acids (including their salts, esters, halides and
anhydrides) with $8 peruorinated carbons; (iv)
peruoroalkane sulfonic acids (including their salts, esters,
halides and anhydrides) with $9 peruorinated carbons; (v)
peruorooctane sulfonic acid (PFOS), its salts and
peruorooctane sulfonyl uoride (PFOSF), as listed in Annex B
to the Convention
PFOA, its salts and
PFOA related compounds62
Any related substance (including its salts and polymers)
having a linear or branched peruoroheptyl group with the
formula C7F15– directly attached to another carbon atom, as
one of the structural elements. Any related substance
(including its salts and polymers) having a linear or branched
peruorooctyl group with the formula C8F17– as one of the
structural elements. The following substances are excluded
from this designation: C8F17–X, where X ¼ F, Cl, Br – C8F17–
C(]O)OH, C8F17–C(]O)O–X0 or C8F17–CF2–X0 (where X0 ¼ any
group, including salts)
EU REACH restriction
(REACH Annex XVII entry
68)
PFOA, its salts and
precursors
as well as long-chain (C9–
C20) PFCAs,
their salts and precursors66
PFOA, its salts and precursors as well as long-chain (C9–C20)
PFCAs, their salts and precursors
Order Adding Toxic
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concluded that the use of toxicological studies conducted with
PFHxA to assess 6:2 FTOH exposure may signicantly under-
estimate human health risk.
Challenges with the above groups are the lack of an
exhaustive list of present precursors and analytical methods for
individually measuring all relevant precursors to a specic PFAA
in a certain medium. Although it was primarily developed as
a research tool,70 the total oxidizable precursor (TOP) assay is
a potential solution to quantifying PFAAs and their precursors.
The TOP assay has been primarily applied to quantify precur-
sors that can be oxidized to PFAAs in water samples,70 although
it has further been developed and applied to a wider range of
sample types, e.g. soils,71 paper and textiles.72
Application of the TOP assay usually involves quantifying
PFAAs in samples using targeted analysis before and aer treat-
ment with powerful oxidizing agents.70 The difference between
the levels of PFAAs before and aer treatment is considered to be
an indicator of the total concentration of the oxidizable PFAA
precursors, because PFCAs and PFSAs that were present in the
original sample remain mostly intact under the conditions of the
assay. Currently it is not possible to apply the TOP assay to
enforce the PFOA restriction under REACH in Table 1 because,
for example, PFOA might be formed during TOP assay oxidation
from a precursor which is not within the restriction scope.
Levels of PFAAs in drinking water samples could be compared
to drinking water guidelines aer the samples have been treated
with the TOP assay. An advantage of this approach is that
precursors would be included that could be transformed in the
water or metabolized to PFAAs inside the body aer intake. On
the other hand, the TOP assay may not simulate environmental
transformation and metabolic processes accurately. The assay is
an aggressive oxidation process that generates shorter-chain
PFAAs than natural environmental oxidation processes, and
even degrades polyuoroalkyl ether acids with –O–CFH– moie-
ties.73 Furthermore, it may overestimate the contribution of some
precursors to PFAA body burdens, and underestimate others and,
thus, inaccurately estimate the risks. For example, the TOP assay
transforms peruorooctane sulfonamide (FOSA) to PFOA,70
whereas FOSA is likely metabolized to PFOS in vivo in humans.74
An enzyme-based assay would be preferable to simulate biolog-
ical transformations, but is not yet broadly available. Finally, the
TOP assay has not to date been standardized so results from
different laboratories may be inconsistent.75
Total uorine and extractable/adsorbable organouorine
approaches
Driven by the need for fast and inexpensive analytical methods
to determine the presence or absence of PFAS in a given sample
and by the lack of analytical standards for most known and
unknown PFAS, total uorine (TF) and extractable/adsorbable
organouorine measurements have been put forward.72,76–79
These methods could also be used in screening-level exposure
assessments, e.g. to determine if the level of total extractable/
adsorbable organouorine in a sample is below or above
a pre-dened limit, which would trigger further chemical
assessment and management measures including more in-
depth targeted analysis.
TF comprises the sum of all uorine as a surrogate for all
inorganic and organic uorinated substances in a sample.76 TF
can be measured through particle-induced gamma(g)-ray
emission (PIGE) spectroscopy, X-ray photoelectron spectroscopy
(XPS) and combustion ion chromatography (CIC). PIGE spec-
troscopy is an ion beam technique used for the analysis of
uorine in solid materials, and liquids aer solid-phase
extraction.72 XPS has also recently been used for uorine mass
balance experiments in consumer products.77 CIC involves
combusting samples or extracts, collecting uoride ions in
water and then separating them on an ion exchange column,
and has also been applied to consumer products.78
Today, TF is used in Denmark with an official indicator value
of 0.1 mg cm2 for food packaging.80 The indicator value can
help industry and regulators assess whether organic uorinated
substances have been added to paper and cardboard. Further-
more, it can inform if PFAS levels are increasing over time. If the
indicator level is exceeded, this can justify further analyses
needed for risk assessment. The fast application of TF methods
and relatively simple evaluation of results (yes and no for
presence of uorine) is appealing. The relatively high detection
limits of TF methods and lack of specicity (cannot specify if TF
is PFAS) are drawbacks. Assuming a 10 mg sample size, detec-
tion limits for TF were recently reported as 0.8 and 38 mg g1 for
CIC and PIGE in paper samples, respectively, which is at least
Table 2 Grouping of PFAAs and their precursors currently under discussion
Substances Context
Undecauorohexanoic acid (PFHxA), its salts and related substances67 EU REACH restriction proposal
Peruorononan-1-oic acid (PFNA); nonadecauorodecanoic acid (PFDA);
henicosauoroundecanoic acid (PFUnDA); tricosauorododecanoic acid
(PFDoDA); pentacosauorotridecanoic acid (PFTrDA); heptacosauoro-
tetradecanoic acid (PFTDA) including their salts and precursors68
EU REACH restriction proposal
PFHxS, its salts and PFHxS-related compounds as well as polymers and
mixtures64
Proposed for listing under the Stockholm
Convention on Persistent Organic Pollutants
PFHxS, its salts and related substances69 EU REACH restriction proposal
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1000 times higher compared to modern PFAS analysis by liquid
chromatograph-tandem mass spectrometry (LC-MS/MS).78
Depending on the sample type, a certain fraction of the TF
can be extracted using organic solvents (extractable organic
uorine, EOF). Alternatively, the PFAS in aqueous samples can
be extracted using a sorbent, which is then analyzed for TF
(adsorbable organic uorine, AOF). The EOF/AOF fraction in
a sample can be assumed to contain primarily synthetic orga-
nouorine substances given the low abundance of naturally
occurring ones, rarely exceeding more than one uorine per
molecule.79 By comparing the concentration of EOF/AOF with
the total PFAS measured in a sample by targeted analysis, the
fractions of known and unknown organouorine substances
can be determined. If the unknown fraction of organouorine
substances is large in a given sample, then this can be probed
using non-targeted analytical methods.14,57,81 As shown in recent
literature, the explainable contributions of EOF to the TF in,
e.g., cosmetics,82 seawater,83 food packaging,78 contaminated
water83 and human blood84 may be 0.1–3%, 2%, 5.5%, 30% and
80%, respectively. Fig. 3 illustrates uorine-containing chem-
icals covered by available analytical methods.
For estimating the drinking water exposure to total PFAS, EOF/
AOF could be potentially used instead of targeted analysis for
groups of PFAS. For example, in the EU very likely a ‘PFAS total’
limit of 500 ng L1 will be provisionally set in a recast of the
Drinking Water Directive85 and EOF/AOF could potentially be
used to relatively rapidly determine if a sample is below this
500 ng L1 limit. An advantage of the EOF/AOF approach is that
all PFAS would be captured in a single measurement that is
relatively inexpensive compared to targeted LC-MS/MS methods
for individual PFAS. EOF/AOF measurement approaches may
further help to determine if unknown PFAS are released to the
environment from production sites and are present in drinking
water or a particular product (e.g. ski waxes or food contact
materials). They are therefore good screening approaches that can
be followed up with non- or suspect-targeted analytical methods
to identify substances in the unknown PFAS fraction.14,57,81 A
disadvantage, however, would be uncertainties in translating the
EOF/AOF measurements into risk-based guidelines. A “worst
case” assumption could be that the EOF/AOF concentration is
equal to the concentration of the most toxic PFAS known (e.g.
typically PFOS or PFOA, see Table 1). This approach may be
considered precautionary and protective, but on the other hand,
humans are exposed to a lot of unknown PFAS with unknown
risks, which may be more toxic than the currently known ones.
Another disadvantage of this approach in its application to PFAS
is that it will likely capture organouorine substances that are
currently not considered as PFAS (e.g. uorinated substances
used as pharmaceuticals and pesticides). Finally, a common
problem with TF, EOF/AOF and the TOP assay is that these
methods require further development before they can be
considered sufficiently reliable for regulatory applications. Efforts
are underway to assess, further develop and standardize methods
as well as to conduct inter-laboratory comparison studies.
Simple additive toxicity approach: application to drinking
water standards
Regulatory agencies worldwide have developed guidelines or
advisories for acceptable levels of PFAS in drinking water.
Because there are so many PFAS and only limited toxicological
and toxicokinetic data for most of them, it is challenging to
generate guidelines for individual PFAS, let alone robust
grouping strategies. Some regulatory agencies have grouped
multiple PFAS together and set one limit for the combined (sum
of) concentrations of these chemicals (Table 3). A simple
example is the combined drinking water health advisory of
70 ng L1 set by the US EPA for the sum of PFOA and PFOS.86
The assumptions made in this grouping are that the critical
toxicological endpoint is the same for the two substances (i.e.,
developmental toxicity) and that the margin of safety (MOS, i.e.
the ratio of NOAEL obtained from animal toxicology studies to
the predicted or estimated human exposure level or dose) is
similar. In Sweden, 11 different PFAS87 are grouped with the
limit of 90 ng L1 for the sum of these 11 PFAS, above which
consumption of drinking water is not recommended.
The simple additive toxicity approach has the advantage that
it is easy to understand and environmental or health-based
guidelines can be evaluated with current analytical methods.
Furthermore, it is thought to be protective for humans and the
environment in that the additive toxicity is based on the most
toxic PFAS in the group. Scientic shortcomings of the simple
additive toxicity approach that sums multiple PFAS are that (1)
it assumes an external dose-additive model88,89 whereas elimi-
nation kinetics vary largely among individual PFAS,90 (2) the
identied critical adverse effects, as well as modes and mech-
anisms of action, may vary for individual PFAS,7 (3) mixture
toxicity may not be simply additive even if the critical adverse
effects are the same88,89 and (4) although multiple PFAS are
included in these drinking water standards, many more PFAS
are neglected. Some possible solutions to the highlighted issues
are discussed in the remaining approaches reviewed, below.
Relative potency factor approach
The Dutch National Institute for Public Health and the Envi-
ronment (RIVM) recently developed a mixture toxicity approach
Fig. 3 Schematic of increasing resolution in information detail of
analytical methods used for PFAS analyses.
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for a number of PFAS termed Relative Potency Factors (RPFs).98
RIVM's RPF approach builds on the assumption that the
combined toxicity of two or more substances can be calculated
based on the concept of dose addition, whereby the substances
have the same effect, but differ only in their toxic potencies.
Liver toxicity data were available for a number of PFAS for rats
and mice from which RPFs could be derived. PFOA was the
reference substance and assigned an RPF of 1.0. RPFs were
estimated for 18 other PFAS with values ranging from 0.001 for
PFBS up to 10 for PFDA. Environmental concentrations can be
Table 3 Existing or proposed grouping approaches based on the sum of various PFAS in drinking water
Entity Date Conc. (ng L1) Sum of which PFAS? Background
EU85 2020 (pending
nal adoption)
100; 500 100 ng L1 for sum of 20 PFAS (C4–
C13 PFSAs and C4–C13 PFCAs)
Politically agreed parameter (not based on
risk assessment) based on a precautionary
approach
500 ng L1 for ‘PFAS Total’ – the
total of all PFAS
‘PFAS Total’ suggested to be enforced
through measurement of EOF/AOF
Denmark91 2015 100 C4–C10 PFCAs, PFBS, PFHxS,
PFOS, PFOSA, and 6:2 FTS
Assumes all 12 PFAS are similarly toxic to
PFOS
Sweden87 2014 90 C4–C10 PFCAs, PFBS, PFHxS, PFOS
and 6:2 FTS
Assumes all 11 PFAS are similarly toxic to
PFOS
Australia92 2017 70 PFOS and PFHxS combined, if
both present
Assumes PFHxS is similarly toxic to PFOS
Canada93 2018 200, 600 PFOA and PFOS When PFOS and PFOA are found together in
drinking water, a cumulative toxicity
approach is appliedb
US EPAa86 2016 70 PFOA and PFOS Lifetime health advisory level. Assumes
additive toxicity of PFOA and PFOS
Connecticut
(USA)94
2017 70 PFHpA, PFOA, PFNA, PFHxS and
PFOS
Application of US EPA lifetime health
advisory level to the sum of ve PFAS;
assumes toxicity similar to that of PFOS and
PFOA
Maine (USA)95 2020 70 PFHxS, PFNA, PFHpA, PFOA and
PFOS
Application of US EPA lifetime health
advisory level to the sum of ve PFAS;




2018/19 20 PFHpA, PFOA, PFNA, PFDA,
PFHxS and PFOS
Proposed maximum contaminant level
(MCL) based on similarities in chemical
structure and toxicities of six PFAS to PFOS
and PFOA. Same approach as US EPA
lifetime health advisory level, but includes
an additional uncertainty factor to account
for evidence of toxicities in experimental
animals at lower levels of exposure than
those used by US EPA
Vermont (USA)97 2019 20 PFHpA, PFOA, PFNA, PFHxS and
PFOS
Interim drinking water standard based on
similar health risks of ve PFAS. Difference
to US EPA advisory is due to Vermont's
calculation being based on infant
consumption rates
a Many US States have simply adopted US EPA's recommended Lifetime Health Advisory (LHA) of 70 ppt for PFOA and PFOS in drinking water. Several
states have passed or proposed compound-specic MCLs or health advisories, including California, Michigan, Minnesota, New Hampshire, New Jersey,
North Carolina, Ohio. Some states have recommendations for ground water that are separate from drinking water. Only sum of PFAS parameters are
included. b Cumulative toxicity estimated by adding the ratio of the monitoring result for PFOS to its maximum acceptable concentration (MAC) with
the ratio of the monitoring result for PFOA to its MAC; if the result is below or equal to one, then the water is considered safe for drinking. According
to the Canadian assessment, “science currently does not justify the use of this approach for other PFAS”.93
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converted into PFOA equivalents by multiplying the RPFs by
specic PFAS concentrations. However, questions surrounding
potential synergism of toxic effects remain;99 while observations
for many endpoints have been largely additive, there is some
evidence from in vivo animal studies on specic endpoints and
in vitro studies, for some higher doses, that PFAS impacts may
be synergistic.100 Thus, a successful grouping strategy may need
to be endpoint-specic, in which the additivity of impact for the
most sensitive endpoint will need to be carefully
considered.101,102
The RPFs derived by RIVM were dened using external
exposures in rodents, i.e. based on the administered dose.
Gomis et al.90 demonstrated that the differences in RPF in rats
can be largely explained by differences in the elimination rates
of PFAS. When potencies of PFAS were compared on an
internal dose basis, the differences in potencies disappeared
and the various PFAS were equally potent. This suggests that
relative external potency is in fact largely a measure of accu-
mulation potential, and that it may be possible to set a single
internal dose for a particular endpoint and sum across all
PFAS. Further conrmation is needed that this observation
holds across a wider variety of PFAS structures, as Gomis
et al.90 considered primarily PFAAs. Moreover, the application
of simple addition of effective internal dose across many
PFAS, in the absence of effects data linked to internal dose,
would require more toxicokinetic data than are currently
available. Elimination half-lives can vary by PFAS structure
(chain length and degree of branching), across species, and by
sex. Because of this, grouping for the purpose of wildlife
protection should be based on rst identifying the most
sensitive species and sex. For humans, translation of animal
data would require two key pieces of information: rst,
whether the internal dose effect level is the same, and, second,
the toxicokinetic data and associated model required to
translate the effective internal dose in the human back to an
external dose that can be associated with an exposure medium
(e.g. drinking water).
Finally, the RPF approach may be difficult to reconcile for
substances that have the potential to biotransform; should the
parent compound, the metabolite, or both be considered in the
calculation? In each case, is there a temporal component that
needs to be taken into account, in addition to the toxicokinetic
considerations suggested above? For example, cellular assays
suggest that reactive intermediate degradation products of u-
orotelomer alcohols, such as short-chain saturated and unsat-
urated uorotelomer aldehydes, are more toxic than either the
parent compound or the terminal PFCA transformation
products.103,104
The specic RPF approach suggested by RIVM is sound if it
can be argued that liver hypertrophy is a sensitive and reliable
endpoint for all PFAAs; a problem here is that many regulatory
jurisdictions disagree with that assessment. However, a similar
additive toxicity approach could potentially be applied for those
other endpoints. The RPF approach is currently limited by the
database of toxicity data available for PFAS. Expanding this
knowledge base would require a large number of animal
experiments and associated ethical considerations, time and
money.
Grouping only PFAAs with the same adverse effect, modes and
mechanisms of action, and toxicokinetics
The most demanding grouping approach would be to only
group PFAS that have the same adverse effects, modes and
mechanisms of action, and toxicokinetics for risk assessment.
The clear disadvantages with an approach of this kind are that
(1) very few substances are likely to be grouped together given
that there is currently no agreement on a single mode and
mechanism of action for even the well-studied PFCAs and
PFSAs,7 (2) modes and mechanisms of action may be tissue or
system-specic, requiring a determination of the most sensitive
or reliable effect for grouping, (3) detailed effect and kinetic
data are needed for each PFAS, such that individual chemicals
would still need extensive toxicological proles and (4) many
groups will be required. Such a grouping approach can be
considered only a marginal improvement on conducting risk
assessments on a chemical-by-chemical basis.
Remaining challenges and the way
forward
There are a number of challenges if the PFAS grouping
approaches summarized in this article are to be integrated into
chemical regulation and company policies, namely; (1) the
universe of PFAS2 has not been fully mapped and divided into
subcategories, (2) only for a few PFAS (e.g. certain PFAAs and
their precursors) is there sufficient information available to
conduct detailed hazard and risk assessments, whereas little or
no information exists on production volumes, properties and
toxic effects for the vast majority of PFAS,3,8 and (3) no single
grouping strategy may be adequate for all decision contexts.
Each of these challenges will be discussed in turn below.
Within the universe of PFAS, most research to date has
focused on the occurrence and effects of certain PFAAs and their
precursors due to the availability of analytical methods and
standards for these substances. Expanding beyond this domain
has been challenging because the chemical composition of
most remaining commercial products is unknown. These
factors are slowly becoming less of a barrier for identifying
overlooked and unknown PFAS due to the recent advancement
of non- and suspect-targeted screening techniques.14,57,81
However, these screening analytical methods are extremely
challenging to apply, even by experts, and the lack of methods
and analytical standards for a wider range of PFAS will remain
a barrier for regulatory purposes.
Depending on the grouping strategies to be taken by indi-
vidual regulatory agencies and companies, there will inevitably
be efforts in the coming years to generate the missing data for
some of the thousands of PFAS. To address these data issues,
the US EPA in partnership with the US National Toxicology
Program (NTP) has recently selected 150 PFAS (expanded from
75 10,86,105) for high-throughput toxicity testing (e.g. in vitro
assays) for multiple endpoints.106 Selection criteria for this
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subset of 150 PFAS included maximizing information to
support read-across within structure-based groupings and
capturing the structural diversity of the PFAS landscape. The
new toxicity and toxicokinetic data generated from this initia-
tive will support the development of quantitative structure–
activity relationships (QSARs) that could facilitate lling data
gaps, as well as further grouping and prioritization of the
universe of PFAS. There are clearly relationships between PFAS
structural elements and properties and behaviour (e.g. number
of uorinated carbons in the peruoroalkyl(ether) chain,
protein binding affinities, bioaccumulation potential, elimina-
tion rates, bioactivities within the PFAA/peruoroalkylether
acid subclasses),11,44,90,107 but on the other hand, critical toxic
endpoints, as well as modes and mechanisms of action vary
within the PFAS and such inconsistencies could limit the
applicability of QSARs and thus reliability of computational
tools.
Within the EU, there is already discussion to phase out all
non-essential uses of PFAS based on concerns of the chemical
class as a whole.19 Within the US, as discussed above, the focus
of the US EPA is on developing high-throughput testing
methods for PFAS,106 but otherwise adhering to the traditional
risk assessment paradigm. These differences in approaches are
inevitable given the differences in chemical management
philosophies around the world and motivations to group PFAS.
It is expected that many of the approaches reviewed in this
paper will be taken in parallel by regulatory agencies in the
different countries. In addition, some of the reviewed grouping
approaches could even be combined (e.g. the newly identied
bioaccumulative PFAS could be regulated together with poten-
tial precursors).
An advantage of the precautionary grouping approaches
based on intrinsic properties is that relatively few data are
needed to group PFAS and regulate them. Conversely, tradi-
tional testing and regulation of PFAS on a chemical-by-chemical
basis would require huge resources and the information
required to perform risk assessments would take many years or
decades to generate. Arguably, regulation could never catch up
given that new PFAS continue to be invented and produced.
Regulation is not the only way to reduce the use of harmful PFAS
in society. Since PFAS have come under pressure in society,
there has been much innovation to produce a new generation of
alternative chemical products that aim to provide healthier,
safer, and more sustainable solutions.18,108 It should be possible
for manufacturers to make chemical products that provide the
function required in modern society while limiting or elimi-
nating hazardous impacts over a chemical product's life-cycle.
Some product manufacturers and retailers continue to take
proactive voluntary measures to phase out PFAS from their
supply chains especially where they are non-essential or where
functional non-uorinated alternatives are available. Examples
of retailers who have phased out PFAS from their supply chains
include IKEA,109 Lindex,110 and H&M111 in Sweden, Coop112 in
Denmark, and Vaude113 and Jack Wolfskin114 in Germany. In
some jurisdictions and even internationally, PFAS are also
being phased out from certain use categories, for example, PFAS
will be phased out of use in ski waxes in international
competitions from the winter season of 2020–2021,115 multiple
global manufacturers moved to phase out PFAS from cosmetics
by 2020,116 Denmark will ban PFAS in food contact materials in
2020,117 South Australia will transition away from the use of
PFAS in re-ghting foams by 2020118 and California designated
all PFAS used in carpets and rugs as “Chemicals of Concern”.119
However, given the complexity of supply chains and ignorance
of the full range of PFAS in society, these phase-outs may in
some use cases only be partially successful, and largely focus on
a few well known PFAS.
Given that PFAS will continue to be used in society until
alternatives are developed, scientists should work to identify the
groups and applications of PFAS among those still in use that
have unfavorable properties which make them particular
threats to human and environmental health. However, there is
a justiable concern that approaches requiring multiple
grouping approaches would result in a similarly large usage of
resources as a chemical-by-chemical regulatory approach.
Investing additional public funds for scientists to identify all
troublesome PFAS, their environmental behaviour and effects
could delay broader regulatory action on PFAS. A precautionary
approach with the aim of phasing out the “non-essential” uses
of PFAS18 would reduce future exposures and the high costs of
research, regulation and cleanup of contaminated sites, while
having minimal impacts on daily life and the economy.
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